vs
Cytek Biosciences, Inc.（CTKB）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是STEM, INC.的1.3倍（$62.1M vs $47.1M），STEM, INC.净利率更高（-33.9% vs -70.9%，领先37.0%），Cytek Biosciences, Inc.同比增速更快（8.1% vs -15.6%），过去两年STEM, INC.的营收复合增速更高（36.1% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
CTKB vs STEM — 直观对比
营收规模更大
CTKB
是对方的1.3倍
$47.1M
营收增速更快
CTKB
高出23.7%
-15.6%
净利率更高
STEM
高出37.0%
-70.9%
两年增速更快
STEM
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $47.1M |
| 净利润 | $-44.1M | $-16.0M |
| 毛利率 | 52.9% | 48.9% |
| 营业利润率 | -9.0% | -17.7% |
| 净利率 | -70.9% | -33.9% |
| 营收同比 | 8.1% | -15.6% |
| 净利润同比 | -557.1% | 68.8% |
| 每股收益（稀释后） | — | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBSTEM
| Q4 25 | $62.1M | $47.1M | ||
| Q3 25 | $52.3M | $38.2M | ||
| Q2 25 | $45.6M | $38.4M | ||
| Q1 25 | $41.5M | $32.5M | ||
| Q4 24 | $57.5M | $55.8M | ||
| Q3 24 | $51.5M | $29.3M | ||
| Q2 24 | $46.6M | $34.0M | ||
| Q1 24 | $44.9M | $25.5M |
净利润CTKBSTEM
| Q4 25 | $-44.1M | $-16.0M | ||
| Q3 25 | $-5.5M | $-23.8M | ||
| Q2 25 | $-5.6M | $202.5M | ||
| Q1 25 | $-11.4M | $-25.0M | ||
| Q4 24 | $9.6M | $-51.1M | ||
| Q3 24 | $941.0K | $-148.3M | ||
| Q2 24 | $-10.4M | $-582.3M | ||
| Q1 24 | $-6.2M | $-72.3M |
毛利率CTKBSTEM
| Q4 25 | 52.9% | 48.9% | ||
| Q3 25 | 52.7% | 35.5% | ||
| Q2 25 | 52.3% | 33.4% | ||
| Q1 25 | 48.6% | 32.4% | ||
| Q4 24 | 58.5% | -4.4% | ||
| Q3 24 | 56.3% | 21.2% | ||
| Q2 24 | 54.6% | 27.6% | ||
| Q1 24 | 51.3% | -95.0% |
营业利润率CTKBSTEM
| Q4 25 | -9.0% | -17.7% | ||
| Q3 25 | -17.6% | -33.6% | ||
| Q2 25 | -23.3% | -34.8% | ||
| Q1 25 | -36.1% | -65.0% | ||
| Q4 24 | 5.2% | -84.4% | ||
| Q3 24 | -8.2% | -493.2% | ||
| Q2 24 | -18.3% | -1705.5% | ||
| Q1 24 | -23.9% | -267.0% |
净利率CTKBSTEM
| Q4 25 | -70.9% | -33.9% | ||
| Q3 25 | -10.5% | -62.2% | ||
| Q2 25 | -12.2% | 527.8% | ||
| Q1 25 | -27.5% | -76.9% | ||
| Q4 24 | 16.8% | -91.6% | ||
| Q3 24 | 1.8% | -506.3% | ||
| Q2 24 | -22.4% | -1712.6% | ||
| Q1 24 | -13.8% | -283.9% |
每股收益（稀释后）CTKBSTEM
| Q4 25 | — | $-4.40 | ||
| Q3 25 | — | $-2.84 | ||
| Q2 25 | — | $-1.79 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | — | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | — | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $48.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $-249.4M |
| 总资产 | $461.5M | $308.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBSTEM
| Q4 25 | $90.9M | $48.9M | ||
| Q3 25 | $93.3M | $43.1M | ||
| Q2 25 | $75.5M | $40.8M | ||
| Q1 25 | $95.3M | $58.6M | ||
| Q4 24 | $98.7M | $56.3M | ||
| Q3 24 | $162.3M | $75.4M | ||
| Q2 24 | $177.9M | $89.6M | ||
| Q1 24 | $168.8M | $112.8M |
股东权益CTKBSTEM
| Q4 25 | $341.7M | $-249.4M | ||
| Q3 25 | $378.6M | $-235.7M | ||
| Q2 25 | $377.6M | $-214.1M | ||
| Q1 25 | $379.6M | $-417.5M | ||
| Q4 24 | $395.7M | $-398.4M | ||
| Q3 24 | $385.5M | $-344.1M | ||
| Q2 24 | $389.1M | $-203.2M | ||
| Q1 24 | $392.6M | $371.6M |
总资产CTKBSTEM
| Q4 25 | $461.5M | $308.9M | ||
| Q3 25 | $494.9M | $362.6M | ||
| Q2 25 | $493.3M | $379.2M | ||
| Q1 25 | $482.6M | $405.1M | ||
| Q4 24 | $499.5M | $437.4M | ||
| Q3 24 | $491.2M | $537.8M | ||
| Q2 24 | $483.7M | $691.5M | ||
| Q1 24 | $492.1M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -2.9% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | — |
8季度趋势，按日历期对齐
经营现金流CTKBSTEM
| Q4 25 | $-771.0K | $8.2M | ||
| Q3 25 | $-3.9M | $11.4M | ||
| Q2 25 | $108.0K | $-21.3M | ||
| Q1 25 | $-125.0K | $8.5M | ||
| Q4 24 | $2.0M | $-14.7M | ||
| Q3 24 | $13.2M | $-9.4M | ||
| Q2 24 | $6.2M | $-11.9M | ||
| Q1 24 | $4.0M | $-621.0K |
自由现金流CTKBSTEM
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
自由现金流率CTKBSTEM
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
资本支出强度CTKBSTEM
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
现金转化率CTKBSTEM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
STEM
暂无分部数据
